Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies  >  All News

News : Companies
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

BIA Separations : Selected for Manufacturing Process Development Support for Gene Therapy Pipeline

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/22/2019 | 04:30am EDT

  • BIA Separations will provide expertise in next generation biomolecule purification processes and long-term supply of CIMmultus™ monolithic columns
  • Initial focus on the manufacture of Zolgensma®, a gene therapy for pediatric patients with spinal muscular atrophy (SMA) less than the age of 2 

BIA Separations, a leading biochromatography development and manufacturing company, today announced it is collaborating with AveXis, a Novartis company, to enhance the commercial purification process for its gene therapy pipeline, beginning with Zolgensma® (onasemnogene abeparvovec-xioi), the first U.S. Food and Drug Administration-approved gene therapy indicated for the treatment of pediatric patients with spinal muscular atrophy (SMA) who are less than two years of age.

Zolgensma is a one-time infusion that provides a functional copy of the human SMN gene to halt disease progression through sustained SMN protein expression.

BIA was selected as a result of its expertise in viral and DNA purification, particularly adeno-associated virus (AAV), and chromatographic technology for the purification and analysis of biomolecules.

Aleš Štrancar, CEO of BIA Separations commented:

“We are proud to have been selected to support AveXis’ gene therapy pipeline. We look forward to seeing how Zolgensma helps the SMA community and the whole BIA team is honored to be a part of this important work.”

Andy Stober, Senior Vice President of Technical Operations for AveXis added:

“We are especially grateful that BIA Separations shared, and operated, with the same sense of urgency we did to help bring gene therapy to the SMA community. BIA’s experience with AAV purification and its chromatographic technology were important contributions and we look forward to our continued work together.”

ENDS

About BIA Separations www.biaseparations.com

BIA Separations is the leading developer and manufacturer of CIM® (Convective Interaction Media) monolithic chromatographic columns for production, purification, and analytics of large biomolecules. The company has research and production facilities in Slovenia, with sales offices and distributors throughout the world. BIA Separations’ mission is to develop and produce CIM® monolithic columns of highest quality and provide superior research and method development services for purification and analytics of biomolecules. In addition, the company aims to provide unique in-process control tools to better understand and control the bioprocesses.


© Business Wire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
05:22pIDEANOMICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
05:22pGRANITESHARES PLATINUM TRUST Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
AQ
05:22pPomerantz Law Firm Investigates Claims On Behalf of Investors of Americas Silver Corporation – USAS
GL
05:21pOASIS MIDSTREAM PARTNERS LP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
AQ
05:20pENERGOUS CORP : Change in Directors or Principal Officers (form 8-K)
AQ
05:20pGENERAL ELECTRIC : New Tampa General Hospital center uses human and artificial intelligence to improve patient care
PR
05:20pFACEBOOK : to Let Users Control Their Data From Other Companies--Update
DJ
05:20pPomerantz Law Firm Investigates Claims on Behalf of Investors of Myriad Genetics, Inc. - MYGN
GL
05:19pPIONEER NATURAL RESOURCES : to Webcast Presentation at the Barclays CEO Energy-Power Conference
BU
05:18pKANSAS CITY SOUTHERN : KCS Announces 19th Annual Holiday Express Schedule; Kicks-off Fundraising to Help Kids in Need
PU
Latest news "Companies"
Advertisement